AzTrials
AzTrials

PainNCT03436264

Identifying Neuroimaging Biomarkers, Demographic, Personality and Sensory Factors for Predicting Extreme Pain Responses to Various Experimental Pain Stimulations in Healthy Subjects

An observational study of Pain and Individual Difference, run by Rambam Health Care Campus at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The proneness to react to noxious stimuli varies widely between individuals and pain ratings of seemingly identical noxious stimuli may range from "no pain" to "excruciating pain" . Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Pain, Individual Difference
What is being tested?
MRI
How many people
48 participants
Where
1 siteIsrael
Study dates
1 Mar 2018to 1 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population will consist of 196 healthy participants. Of these, 48 patients will undergo brain imaging

Who may be able to join

  • Healthy males and females, over the age of 18, free from chronic pain of any type.
  • No medication use (except for oral contraceptives).
  • Able to understand the purpose and instructions of the study and to sign an informed consent.

Who cannot join

  • Pregnant women
  • Inability to comply with study protocol.
  • A diagnosis of Raynaud's Syndrome
  • Subjects with metal implants of any kind (including pace maker) and Claustrophobia will be excluded from the study.

Trial locations and contacts

1 site in 1 country.

Israel1 site, 1 recruiting
  • Rambam Health Care Campus

    Haifa, 31096

    Elon Eisenberg, MD, 972 4 8542880, e_eisenberg@rambam.health.gov.il

    Elon Eisenberg, MD

    Recruiting

Other trials in Israel

About this study

The proneness to react to noxious stimuli varies widely between individuals and pain ratings of seemingly identical noxious stimuli may range from "no pain" to "excruciating pain" . Imaging studies in healthy subjects have provided useful information on the identification of the inter-individual variability in pain perception [2,3,4]. These studies have shown that subjective pain reports are closely related to the degree of neuronal activity in several brain regions known to be identified in pain processing. Furthermore, there has been a growing interest in understanding structural and functional mechanisms of inter-individual variability in responses to identical noxious stimuli [5,6,7]. Yet, the relationship between pain perception and various anatomical and functional connectivity within resting state brain networks is not completely understood. With regard to the anatomical correlate of pain sensitivity, differences in grey matter may reflect neural processes contributing to the construction and modulation of pain in healthy individuals. As such, studies are inconsistent regarding this issue, showing positive [7] or inverse connections [6] between pain sensitivity and brain morphology. The inconsistency regarding this issue warrant further investigation which may elucidate the relationship between differences in pain sensitivity and regional grey matter and may provide novel insights into brain mechanisms contributing to that topic. Understanding brain morphology and connectivity within specific regions associated with pain processing can provide reliable anchor for the individual differences in pain response.

A widely used approach to examine brain morphology from MRI images is voxel based morphometry (VBM). VBM tests for statistically significant differences in regional gray matter (GM) density between study groups, and its temporal changes. Diffusion tensor imaging (DTI) is a type of diffusion weighted imaging with the advantage of being able to resolve individual functional tracts within the white matter (WM) thus, DTI parameters serve as indirect measures of structural connectivity via the degree of integrity of WM tracts.

Read the detailed description

Background The proneness to react to noxious stimuli varies widely between individuals and pain ratings of seemingly identical noxious stimuli may range from "no pain" to "excruciating pain" . Imaging studies in healthy subjects have provided useful information on the identification of the inter-individual variability in pain perception [2,3,4]. These studies have shown that subjective pain reports are closely related to the degree of neuronal activity in several brain regions known to be identified in pain processing. Furthermore, there has been a growing interest in understanding structural and functional mechanisms of inter-individual variability in responses to identical noxious stimuli [5,6,7]. Yet, the relationship between pain perception and various anatomical and functional connectivity within resting state brain networks is not completely understood. With regard to the anatomical correlate of pain sensitivity, differences in grey matter may reflect neural processes contributing to the construction and modulation of pain in healthy individuals. As such, studies are inconsistent regarding this issue, showing positive [7] or inverse connections [6] between pain sensitivity and brain morphology. The inconsistency regarding this issue warrant further investigation which may elucidate the relationship between differences in pain sensitivity and regional grey matter and may provide novel insights into brain mechanisms contributing to that topic. Understanding brain morphology and connectivity within specific regions associated with pain processing can provide reliable anchor for the individual differences in pain response.

A widely used approach to examine brain morphology from MRI images is voxel based morphometry (VBM). VBM tests for statistically significant differences in regional gray matter (GM) density between study groups, and its temporal changes. Diffusion tensor imaging (DTI) is a type of diffusion weighted imaging with the advantage of being able to resolve individual functional tracts within the white matter (WM) thus, DTI parameters serve as indirect measures of structural connectivity via the degree of integrity of WM tracts.

  1. Aim of the study To Identify neuroimaging biomarkers, demographic, personality and sensory factors for predicting extreme pain responses to various experimental pain stimulations in healthy subjects 3. Methods 3.1 Sample

The study population will consist of 196 healthy participants. Of these, 48 patients will undergo brain imaging after meeting the following inclusion and exclusion criteria:

Study design The proposed study has been conducted at the Pain Research Laboratory of University of Haifa (in which psychophysics tests will be conducted), and imaging tests will be performed at the Imaging department of Rambam Health Care Campus.

Subjects were recruited through advertisements distributed on campus bulletin board. Responders who met the inclusion criteria were invited to participate in the study. The trial will be held in two independent experimental sessions with an estimated duration of one hour and a half for the psychophysical tests and half an hour for the neuroimaging session.

This study is focused on extreme subgroups only. Therefore, in the first session (which took place in the pain lab) subjects (n=196) were either divided into two subgroups according to their tolerance results to the Cold Pressor Test (CPT) (high tolerance subgroup = 180 s vs. low tolerance subgroup ≤20 s). 24 subjects from each subgroup will be randomly selected and will receive an explanation about the option to participate in the brain imaging test. Subjects who will decide to participate in the imaging test will undergo it at the Imaging Department of Rambam Health Care Campus. Upon arrival, subjects will receive a full explanation of the course and time of the MRI scan of the brain and will be asked to sign an informed consent form. The duration time of the MRI procedure is around half an hour during which no material will be injected or pain tests will be performed.

During the test, several sequences will be performed; three-dimensional high-resolution anatomy, another structural test for the definition of connectivity (DTI), and resting state (RS) fMRI tests to examine the activity of brain networks. MRI will be performed using a 3-Tesla scanner (GE Discovery MR750). The protocol consists of (1) a T1-weighted 3D magnetization-prepared rapid gradient echo (MPRAGE) sequence (176 slices; 220 × 220 matrix; TR = 2520 ms; TE = 1.74 ms; 1.0 × 1.0 × 1.0 mm voxels), (2) an echo-planar imaging (EPI) resting state sequence (34 slices; TR = 2010 ms; TE = 30 ms; 64 × 64 matrix; 3.5 × 3.5 × 5 mm voxels 200 volumes lag=4 RTs), (3) a diffusion-weighted imaging (DTI) sequence (70 slices; TR = 4600 ms; TE = 89 ms; 2 × 2 × 2 mm voxels) using non-collinear 64 directions and a single non-diffusion weighted (b = 0 s/mm2) image. At the end of the examination, analyzes of the data will be carried out for each individual and for each population of the study. After the MRI scan subjects will be asked to fill out the depression, anxiety and stress scales (DASS): The DASS assess depression, anxiety and stress with 7 Items each (Henry \& Crawford, 2005). The DASS-Depression focuses on reports of low mood, motivation, and self-esteem, DASS-anxiety on physiological arousal, perceived panic, and fear, and DASS-stress on tension and irritability. The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. It was validated in a population of over 300 patients with chronic pain as well as healthy volunteers and found valid and reliable in both populations.

Being tested
MRI
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIOther

    fMRI

Study groups in NCT03436264
Study groupRoleWhat they receive
high sensitivity to painNot described
Receives: Other: MRI
low sensitivity to painNot described
Receives: Other: MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. fMRI diffrences

    1. Both subgroups will demonstrate differences in gray matter density and cortical thickness in key cortical regions that are responsible for the processing and modulation of sensory stimuli, such as primary somatosensory cortex (S1), cingulate cortex (ACC/MCC/PCC), prefrontal cortex (PFC including OFC) and insula.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2018
  2. Study start1 Mar 2018
  3. Primary completion1 Dec 2019 (estimated)
  4. Study completion1 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03436264
Sponsor's protocol ID
0448-17
Status last verified
Apr 2018
First submitted
31 Jan 2018
Last updated
24 Apr 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Pain and Individual Difference, run by Rambam Health Care Campus at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eisenberg (972502061091, e_eisenberg@rambam.health.gov.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

fMRI diffrences (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in